Dr. DaCosta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
48 Route 25a Ste 209
Smithtown, NY 11787Phone+1 631-751-3000Fax+1 631-509-6559
Education & Training
Stony Brook Medicine/University HospitalFellowship, Hematology and Medical Oncology, 1989 - 1992
Zucker School of Medicine at Hofstra/Northwell at Forest Hills HospitalResidency, Internal Medicine, 1986 - 1989
Seth G.S. Medical CollegeClass of 1984
Certifications & Licensure
NY State Medical License 1993 - 2026
NJ State Medical License 2019 - 2025
MI State Medical License 1992 - 2005
TN State Medical License 1995 - 2004
VA State Medical License 1992 - 2004
KY State Medical License 1992 - 2000- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2014
- Newsday - Top Doctors on Long Island Castle Connolly, 2013-2014
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2011-2013
Clinical Trials
- CYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448) Start of enrollment: 2015 Aug 01
Publications & Presentations
PubMed
- 1 citationsUncovering the Uncommon: An 81-Year-Old Woman With Elevated Carcinoembryonic Antigen (CEA) but Normal Calcitonin Levels Diagnosed With Medullary Thyroid Carcinoma.Janta Ukrani, Martin Barnes, Aqsa Ashraf, Gregory Haggerty, Noshir Dacosta
Cureus. 2023-06-01 - Necrobiosis lipoidica in a patient with monoclonal gammopathy of underdetermined significanceNadeem G. Marghoob, Sarah Schmitz, Ashfaq A. Marghoob, Michael K Miller, Noshir Dacosta
The Australasian Journal of Dermatology. 2019-06-03 - 193 citationsPhase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a TaxaneLinda T. Vahdat, Brian Pruitt, Carol J. Fabian, Ragene Rivera, David Smith
Journal of Clinical Oncology. 2009-06-20
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
